Keʻena Honua

Ma ke kahua honua o ka ʻike ʻana a me ka mālama ʻana i ka maʻi kanesa māmā, ʻo ka ʻike mua ʻana a me ka mālama pololei ʻana i nā nodules pulmonary ke kikowaena o ka nānā ʻana i ke olakino. Ma ke ʻano he mau aka paʻa i ke kiʻi ʻana i ka māmā, he ʻokoʻa ke ʻano o nā nodules pulmonary, mai ka mumū maikaʻi a hiki i ka maʻi mua...E heluhelu hou aku»

Ma ke ala e hakakā ai i ka maʻi kanesa, ua ʻimi mau ke kaiāulu lapaʻau i nā ʻano lapaʻau ʻoi aku ka maikaʻi a me ka palekana. ʻOiai ua hoʻokumu ke ʻoki kino, radiotherapy, chemotherapy, a me biotherapy i kahi kahua paʻa no ka mālama ʻana i ka maʻi kanesa, ʻo ka hyperthermia—kahi ʻenehana hou i loaʻa mai ka naʻauao kahiko—...E heluhelu hou aku»

I ke alo ʻana i kahi maʻi kanesa, ʻo ka manaʻolana like o nā mea maʻi ma ka honua holoʻokoʻa e loaʻa i ke koho lapaʻau kūpono loa, holomua, a me ka minimally invasive. Inā ʻoe e ʻimi nei i kahi haukapila e hoʻohui i ka ʻike loea lapaʻau Kina kiʻekiʻe, ka ʻenehana holomua, a me nā lawelawe maʻamau o ka honua, ʻo ka...E heluhelu hou aku»

Ke kū nei ʻoe a i ʻole kahi mea aloha i kahi maʻi kanesa a manaʻo ʻoe ua palena a manaʻolana ʻole paha i ka wā e ʻimi ana i nā koho lapaʻau ma kahi kūloko, ke noʻonoʻo nei paha ʻoe: Ma kēlā ʻaoʻao o ka honua, aia kekahi mau koho lapaʻau holomua, emi iki ka invasive, a ʻoi aku ka manaʻolana? No nā nīnau e pili ana i ka lāʻau lapaʻau kanesa hou...E heluhelu hou aku»

Ua ʻike kekahi maʻi maʻi ʻaʻai lolo hope loa, ka mea i hoʻi hou ma hope o 17 mau lāʻau CAR-T, ua nalowale loa kāna puʻupuʻu i loko o 4 mau pule o ka loaʻa ʻana o kahi lāʻau lapaʻau TIL hou a ua noho ʻole ʻo ia me ka puʻupuʻu no nā mahina he 20 a ʻoi. No nā nīnau e pili ana i nā lāʻau lapaʻau hou a me nā hoʻokolohua lapaʻau: Kelepona: 4008803716 | WeChat:...E heluhelu hou aku»

Nowemapa 17, 2025, ua hoʻolaha ʻo Abbisko i ka hōʻike ʻana o ka hopena lōʻihi, ka palekana a me nā hopena i hōʻike ʻia e ka mea maʻi mai ka noiʻi honua Phase III MANEUVER o pimicotinib (ABSK021) i nā poʻe maʻi me ka tenosynovial giant cell tumor (TGCT) ma ka Connective Tissue Oncology Society (CTOS) 2025 ...E heluhelu hou aku»

Kepakemapa 8, 2025, ua hoʻolaha ʻo InnoCare Pharma ua ʻāpono ʻia ʻo HIBRUKA (orelabrutinib) e ka Health Sciences Authority (HSA) o Singapore no ka mālama ʻana i nā poʻe maʻi makua me ka relapsed a i ʻole refractory marginal zone lymphoma (R/R MZL). I kēia manawa, nui nā hoʻokolohua lapaʻau o nā mea hou...E heluhelu hou aku»

Ma ʻAukake 28, ua hoʻolaha ke Kikowaena no ka Loiloi Lāʻau Lapaʻau (CDE) o ka National Medical Products Administration (NMPA) ua manaʻo ʻia ʻo BL-B01D1 no ka inikini e hoʻokomo ʻia i loko o ke kaʻina loiloi koʻikoʻi. Ua manaʻo ʻia no nā poʻe maʻi me ka carcinoma nasopharyngeal recurrent a metastatic paha i loaʻa mua...E heluhelu hou aku»

ʻAukake 21, ua hāʻawi ʻia ka bispecific T cell engager, ʻo epcoritamab, i ka loiloi mua e ke Center for Drug Evaluation (CDE) o ka National Medical Products Administration (NMPA). Kuhi ʻia ka ʻae ʻia i nā poʻe maʻi makua me ka relapsed a refractory follicular lymphoma (FL), kahi subset pono nui o...E heluhelu hou aku»

ʻAukake 29, ua ʻāpono ʻia ʻo Boehringer Ingelheim's HERNEXEOS® (nā papa zongertinib) ma ke ʻano he monotherapy e ka National Medical Products Administration (NMPA) o Kina no ka mālama ʻana i nā poʻe maʻi makua me ka maʻi kanesa māmā ʻaʻole liʻiliʻi (NSCLC) i hiki ʻole ke hoʻopau ʻia, kūloko holomua a metastatic paha nona nā puʻupuʻu ...E heluhelu hou aku»

Ma ʻAukake 22, 2025, ua loaʻa iā Datopotamab deruxtecan (Dato-DXd; Datroway) ka ʻae ʻia ma Kina no ka mālama ʻana i nā maʻi makua me ka unresectable a metastatic hormone receptor-positive, HER2-negative (immunohistochemistry [IHC] 0, IHC 1+, a i ʻole IHC 2+/in situ hybridization [ISH] negative) umauma...E heluhelu hou aku»

I ʻAukake 2025, ua hāʻawi kūhelu ke Center for Drug Evaluation (CDE) o ka National Medical Products Administration (NMPA) i ka Breakthrough Therapy Designation iā Ina-cel, kahi lāʻau lapaʻau CAR-T hou i kuhikuhi ʻia e CD19 i hoʻomohala kūʻokoʻa ʻia e Juventas, no ka mālama ʻana i nā maʻi pediatric me ka re...E heluhelu hou aku»